Home › Funds › Seilern Investment Management Ltd › WST

Seilern Investment Management Ltd position in WST

WEST PHARMACEUTICAL SVSC INC · Health Care

Seilern Investment Management Ltd reported holding 120,729 shares of WST (WEST PHARMACEUTICAL SVSC INC) in its Q3 2026 13F filing — a position valued at US$44.8M, representing 5.80% of its reported portfolio and ranking #9 among its reported holdings. Seilern Investment Management Ltd has disclosed WST holdings in 8 of the last 8 reported quarters, going back to Q4 2024.

Latest position (Q3 2026)120.73K sh
Reported value held$44.76M
Portfolio Weight5.80%
First reportedQ4 2024
Last changeReduce
Updated2026-10-15

Last updated: 2026-10-15 · Source: SEC EDGAR Form 13F-HR

How Seilern Investment Management Ltd's WST position evolved

Seilern Investment Management Ltd first disclosed a stake in WST in Q4 2024 at 443,825 shares (US$145.4M). Across 8 filings, Seilern Investment Management Ltd increased the stake 0 time(s), trimmed it 7 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 120,729 shares valued at US$44.8M — a reduction of -17,501 shares quarter over quarter.. Notable position changes include a 39% trim in Q2 2026 (shares rose 3% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2024 443.82K $145.38M New
Q1 2025 441.36K $98.81M Reduce
Q2 2025 431.56K $94.43M Reduce
Q3 2025 326.96K $85.77M Reduce
Q4 2025 278.23K $76.55M Reduce
Q1 2026 226.02K $56.65M Reduce
Q2 2026 138.23K $49.62M Reduce
Q3 2026 120.73K $44.76M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About WST and 13F data

WST (WEST PHARMACEUTICAL SVSC INC) is a Health Care company. 35 other funds we track also report a position in WST — the largest reported positions include Artisan Partners Limited Partnership (US$865.8M), GENERATION INVESTMENT MANAGEMENT LLP (US$728.2M), BROWN ADVISORY INC (US$386.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding WST

All WST fund holders →

FAQ

How long has Seilern Investment Management Ltd held WST?

Seilern Investment Management Ltd has disclosed WST holdings in 8 of the last 8 reported quarters, going back to Q4 2024.

What is Seilern Investment Management Ltd's current position in WST?

As of Q3 2026, Seilern Investment Management Ltd holds 120.73K shares of WST (WEST PHARMACEUTICAL SVSC INC), valued at $44.76M, representing 5.80% of its reported portfolio and ranking #9.

Has Seilern Investment Management Ltd been buying or selling WST?

In the latest 13F filing (Q3 2026), Seilern Investment Management Ltd reduced its position in WST.

Which other funds hold WST?

Other major institutional holders of WST include Artisan Partners Limited Partnership, GENERATION INVESTMENT MANAGEMENT LLP, BROWN ADVISORY INC, among 35 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.